MCM
KRRO icon

MAI Capital Management’s Korro Bio KRRO Stock Holding History

MAI Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.86K Buy
606
+601
+12,020% +$6.62K ﹤0.01% 3344
2025
Q4 		$41 Hold
5
– – ﹤0.01% 4259
2025
Q3 		$240 Hold
5
– – ﹤0.01% 3693
2025
Q2 		$63 Hold
5
– – ﹤0.01% 3909
2025
Q1 		$88 Hold
5
– – ﹤0.01% 3365
2024
Q4 		$191 Buy
+5
New +$257 ﹤0.01% 3378

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

MAI Capital Management's KRRO Position: Q1 2026 in Review

MAI Capital Management increased its Korro Bio (KRRO) stake by 12,020% in Q1 2026, buying an estimated $6.62K and bringing the position to 606 shares worth $6.86K. The position accounts for ﹤0.01% of the portfolio, ranked #3344.

MAI Capital Management first reported a position in KRRO in Q4 2024 and has held it in 6 quarters since. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • MAI Capital Management held 606 shares of Korro Bio worth $6.86K as of Q1 2026.
  • MAI Capital Management bought 601 Korro Bio shares in Q1 2026, an estimated $6.62K.
  • Korro Bio made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3344 holding.
  • MAI Capital Management first reported a position in Korro Bio in Q4 2024 and has held it in 6 quarters since.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.